Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand?

Tom Marcelissen; Tina Rashid; Tiago Antunes Lopes; Nicolas Barry Delongchamps; Bogdan Geavlete; Malte Rieken; Jean-Nicolas Cornu; Mohammad Sajjad Rahnama'i; EAU Young Academic Urologists (YAU) Functional Urology Working Group

doi:10.1016/j.euf.2018.03.011

Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand?

Tom Marcelissen, Tina Rashid, Tiago Antunes Lopes, Nicolas Barry Delongchamps, Bogdan Geavlete, Malte Rieken, Jean-Nicolas Cornu, Mohammad Sajjad Rahnama'i^*, EAU Young Academic Urologists (YAU) Functional Urology Working Group

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

6 Citations (Web of Science)

Original language	English
Pages (from-to)	1112-1119
Number of pages	8
Journal	European Urology Focus
Volume	5
Issue number	6
DOIs	https://doi.org/10.1016/j.euf.2018.03.011
Publication status	Published - Nov 2019

Keywords

Drug
Incontinence
Medication
Overactive bladder syndrome
Pharmacology
Urgency
DOUBLE-BLIND
ANTIMUSCARINIC AGENTS
COGNITIVE FUNCTION
ANTICHOLINERGIC PROPERTIES
MIRABEGRON
EFFICACY
SOLIFENACIN
ADHERENCE
PERSISTENCE
THERAPY

Access to Document

10.1016/j.euf.2018.03.011

Cite this

Marcelissen, Tom ; Rashid, Tina ; Lopes, Tiago Antunes ; Delongchamps, Nicolas Barry ; Geavlete, Bogdan ; Rieken, Malte ; Cornu, Jean-Nicolas ; Rahnama'i, Mohammad Sajjad ; EAU Young Academic Urologists (YAU) Functional Urology Working Group. / Oral Pharmacologic Management of Overactive Bladder Syndrome : Where Do We Stand?. In: European Urology Focus. 2019 ; Vol. 5, No. 6. pp. 1112-1119.

@article{d9c18362ae95486a84bb913bff1c73e3,

title = "Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand?",

keywords = "Drug, Incontinence, Medication, Overactive bladder syndrome, Pharmacology, Urgency, DOUBLE-BLIND, ANTIMUSCARINIC AGENTS, COGNITIVE FUNCTION, ANTICHOLINERGIC PROPERTIES, MIRABEGRON, EFFICACY, SOLIFENACIN, ADHERENCE, PERSISTENCE, THERAPY",

author = "Tom Marcelissen and Tina Rashid and Lopes, {Tiago Antunes} and Delongchamps, {Nicolas Barry} and Bogdan Geavlete and Malte Rieken and Jean-Nicolas Cornu and Rahnama'i, {Mohammad Sajjad} and {EAU Young Academic Urologists (YAU) Functional Urology Working Group}",

year = "2019",

month = nov,

doi = "10.1016/j.euf.2018.03.011",

language = "English",

volume = "5",

pages = "1112--1119",

journal = "European Urology Focus",

issn = "2405-4569",

publisher = "Elsevier",

number = "6",

}

Oral Pharmacologic Management of Overactive Bladder Syndrome : Where Do We Stand? / Marcelissen, Tom; Rashid, Tina; Lopes, Tiago Antunes; Delongchamps, Nicolas Barry; Geavlete, Bogdan; Rieken, Malte; Cornu, Jean-Nicolas; Rahnama'i, Mohammad Sajjad; EAU Young Academic Urologists (YAU) Functional Urology Working Group.

In: European Urology Focus, Vol. 5, No. 6, 11.2019, p. 1112-1119.

Research output: Contribution to journal › Review article › Academic › peer-review

TY - JOUR

T1 - Oral Pharmacologic Management of Overactive Bladder Syndrome

T2 - Where Do We Stand?

AU - Marcelissen, Tom

AU - Rashid, Tina

AU - Lopes, Tiago Antunes

AU - Delongchamps, Nicolas Barry

AU - Geavlete, Bogdan

AU - Rieken, Malte

AU - Cornu, Jean-Nicolas

AU - Rahnama'i, Mohammad Sajjad

AU - EAU Young Academic Urologists (YAU) Functional Urology Working Group

PY - 2019/11

Y1 - 2019/11

KW - Drug

KW - Incontinence

KW - Medication

KW - Overactive bladder syndrome

KW - Pharmacology

KW - Urgency

KW - DOUBLE-BLIND

KW - ANTIMUSCARINIC AGENTS

KW - COGNITIVE FUNCTION

KW - ANTICHOLINERGIC PROPERTIES

KW - MIRABEGRON

KW - EFFICACY

KW - SOLIFENACIN

KW - ADHERENCE

KW - PERSISTENCE

KW - THERAPY

U2 - 10.1016/j.euf.2018.03.011

DO - 10.1016/j.euf.2018.03.011

M3 - Review article

C2 - 29625926

VL - 5

SP - 1112

EP - 1119

JO - European Urology Focus

JF - European Urology Focus

SN - 2405-4569

IS - 6

ER -